Bafna Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 419.47 million compared to INR 169.27 million a year ago. Revenue was INR 438.16 million compared to INR 182.31 million a year ago.

Net income was INR 63.51 million compared to INR 13.62 million a year ago. Basic earnings per share from continuing operations was INR 2.68 compared to INR 0.58 a year ago. Diluted earnings per share from continuing operations was INR 2.68 compared to INR 0.58 a year ago.